Cartesian Therapeutics Inc (RNAC)
Financing Cash Flow
$50.25M
TTM · Period ending: · USD
RNAC Financing Cash Flow
Latest reported$50.25Mperiod ending
Latest reported$50.25Mperiod ending
RNAC Cash from Financing ($24.77M → $50.25M)
Annual financing cash flow
High-resolution chart · PNG
RNAC financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -8,055,000 | |
| 168,428,000 | |
| -13,145,000 | |
| 39,215,000 | |
| 52,897,000 | |
| 14,431,000 | |
| 105,041,000 | |
| 697,000 | |
| 66,023,000 | |
| 67,659,000 | |
| 43,906,000 | |
| 24,771,000 |